ArticleJournal of substance abuse treatment2018
Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.
Article in Journal of substance abuse treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention.Journal of substance abuse treatment · 2022Trial
- Continuity of Medications for Opioid Use Disorder in States With and Without Medicaid Prescription Cap Policies.Medical care · 2026Article
- Association of state medicaid prescription cap policies with trajectories of buprenorphine use for opioid use disorder.Journal of substance use and addiction treatment · 2025Article
- Medicaid prescription cap policies and acute care use and mortality among enrollees with opioid use disorder.Drug and alcohol dependence · 2025Article
- Harm Reduction and Treatment Among People at High Risk of Overdose.JAMA network open · 2024Article
- The Impact of State Medicaid Eligibility and Benefits Policy on Neonatal Abstinence Syndrome Hospitalizations.Contemporary economic policy · 2024Article
- State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.JAMA health forum · 2023Article
- Association Between Medicaid Managed Care Coverage of Substance Use Services and Treatment Utilization.JAMA health forum · 2022Article
- A bifurcated opioid treatment system and widening insidious disparities.Addictive behaviors · 2022Article
- Medicaid Expansion and Low-Income Adults with Substance Use Disorders.The journal of behavioral health services & research · 2021Article
- The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.Health services research · 2020Article
- Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.Medical care · 2020Observational
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020Review
- Medicaid coverage in substance use disorder treatment after the affordable care act.Journal of substance abuse treatment · 2019Article
- Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act.Drug and alcohol dependence · 2019Article
- Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs.American journal of public health · 2019Article
- A Public Health Strategy for the Opioid Crisis.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo assess the relationship of restrictions on Medicaid benefits for addiction treatment to Medicaid acceptance among addiction treatment programs. DATA SOURCES: We collected primary data from the 2013-2014 wave of the National Drug Abuse Treatment System Survey. STUDY
designWe created two measures of benefits restrictiveness. In the first, we calculated the number of addiction treatment services covered by each state Medicaid program. In the second, we calculated the total number of utilization controls imposed on each service. Using a mixed-effects logistic regression model, we estimated the relationship between state Medicaid benefit restrictiveness for addiction treatment and adjusted odds of Medicaid acceptance among addiction treatment programs. DATA COLLECTION: Study data come from a nationally-representative sample of 695 addiction treatment programs (85.5% response rate), representatives from Medicaid programs in forty-seven states and the District of Columbia (response rate 92%), and data collected by the American Society for Addiction Medicine. PRINCIPAL
findingsAddiction treatment programs in states with more restrictive Medicaid benefits for addiction treatment had lower odds of accepting Medicaid enrollees (AOR = 0.65; CI = 0.43, 0.97). The predicted probability of Medicaid acceptance was 35.4% in highly restrictive states, 48.3% in moderately restrictive states, and 61.2% in the least restrictive states.
conclusionsAddiction treatment programs are more likely to accept Medicaid in states with less restrictive benefits for addiction treatment. Program ownership and technological infrastructure also play an important role in increasing Medicaid acceptance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.